Welcome: Guest | Site Use Options | Register | Login |

nanoDerm Sciences Inc

Profile last edited on: 4/12/2017
16618 Kipling Road
Derwood, MD 20855
  (703) 994-5856
Business Identifier: Wound Healing and Drug Delivery
Public Profile:
The company, nanoDERM Sciences, Inc. (nDS), is an early stage therapeutic products developer and Institute for Life Science Entrepreneurship (ILSE) member with laboratories in Union, NJ. The company, founder and CEO, Roy Yeoman, leads the nDS R&D team which is dedicated to the discovery, research, development, and commercialization of innovative drug delivery, advanced wound healing, and infectious disease therapy products. The firm's focus is on a nanotechnology platform for drug delivery to address drug-resistent bacteria. The firm's goal is to produce antibacterial nanomedicine to combat Burn Wound Sepsis, the most common and serious complication of major burn injury, accounting for over 60% of deaths in burn patients today.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Targeted Therapeutic Nanogels for Effective Treatment of Multidrug-Resistant Bacteria in Wounds

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920